RAPID MICRO BIOSYSTEMS INC RPID
CLASS A COM · Common Stock · CUSIP 75340L104
- SectorTechnology
- IndustryLaboratory Analytical Instruments
- HeadquartersLexington, MA
- FilingsSEC EDGAR
43
institutional holders
-11 vs Q3 2022
24.5m
shares reported held*
$27.7mreported value*
4 new
12 added
14 reduced
14 sold out
net sold ≈ $1.2m (-1.1m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.13.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 54 |
| Q4 2022 | 43 |
Biggest buyers
| GOLDMAN SACHS GROUP INC | Added | +1.0m |
| JACOBS LEVY EQUITY MANAGEMENT, INC | New | +161.4k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Added | +69.5k |
| GLENVIEW CAPITAL MANAGEMENT, LLC | Added | +60.4k |
| Magnetar Financial LLC | Added | +21.9k |
| CITADEL ADVISORS LLC | New | +20.7k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +5.5k |
| Belpointe Asset Management LLC | New | +3.1k |
| Schonfeld Strategic Advisors LLC | Added | +2.5k |
| BOOTHBAY FUND MANAGEMENT, LLC | Added | +1.9k |
Biggest sellers
| JPMORGAN CHASE & CO | Reduced | -1.4m |
| T. Rowe Price Investment Management, Inc. | Reduced | -452.4k |
| Arena Investors LP | Reduced | -188.1k |
| AMERIPRISE FINANCIAL INC | Sold out | -50.9k |
| TPG GP A, LLC | Sold out | -47.9k |
| Ergoteles LLC | Reduced | -38.9k |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | -37.4k |
| CAAS CAPITAL MANAGEMENT LP | Sold out | -27.8k |
| Alpine Global Management, LLC | Sold out | -25.9k |
| GSA CAPITAL PARTNERS LLP | Sold out | -23.1k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Bain Capital Life Sciences Fund, L.P. 13G · exempt (held before listing) filed 2026-08-14 | 16.8% |
| Longitude Capital Partners II, LLC 13G · exempt (held before listing) filed 2026-05-15 | 8.6% |
| ARMISTICE CAPITAL, LLC 13G · institution new · filed 2026-08-14 | 7.3% |
Spignesi Robert G. Jr.
13D · may seek influence
new · filed 2025-08-19
Stated purposeThe information set forth or incorporated by reference in Items 3 and 6 of this Statement is incorporated by reference into this Item 4. The Reporting Person intends to continuously review his investment in the Issuer and may in the future determine (1) to acquire additional securities of the Issuer, through open market purchases, private agreements or otherwise, (2) to dispose of all or a portion of the securities of the Issuer owned by him or (3) to take any other available course of action. Notwithstanding anything contained herein, the Reporting Person specifically reserves the right to change his intention with respect to any or all of such matters. In reaching any decision as to his course of action (as well as to the specific elements thereof), the Reporting Person currently expect… Full filing |
6.3% |
| Endeavour Medtech Growth II LP 13G · passive investor filed 2026-02-13 | 5.7% |
Insider purchases and sales in Q4 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
BuyingSelling
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 1 | $69.5k | 0 | — | — |
| Q2 2022 | 1 | $38.0k | 0 | — | — |
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
None reported in Q4 2022.
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC 1.07% of their portfolio | 8.4m $9.5m | Unchanged |
| KENNEDY LEWIS MANAGEMENT LP 8.41% of their portfolio | 4.9m $5.6m | Unchanged |
| T. Rowe Price Investment Management, Inc. 0.00% of their portfolio | 2.2m $2.5m | Reduced -452.4k |
| ABG-WTT Global Life Science Capital Partners GP Ltd 18.96% of their portfolio | 1.0m $1.2m | Unchanged |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 1.0m $1.2m | Added +1.0m |
| BlackRock Inc. 0.00% of their portfolio | 1.0m $1.2m | Reduced -13.5k |
| GLENVIEW CAPITAL MANAGEMENT, LLC 0.02% of their portfolio | 810.4k $915.7k | Added +60.4k |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 800.5k $905.0k | Reduced -37.4k |
| VANGUARD GROUP INC 0.00% of their portfolio | 729.6k $824.4k | Added +190 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.00% of their portfolio | 716.2k $809.3k | Unchanged |
| Ally Bridge Group (NY) LLC 0.77% of their portfolio | 699.7k $790.6k | Unchanged |
| Advent International, L.P. 0.01% of their portfolio | 577.8k $652.9k | Unchanged |
| Rhenman & Partners Asset Management AB 0.04% of their portfolio | 300.0k $339.0k | Unchanged |
| Oasis Management Co Ltd. 0.05% of their portfolio | 187.6k $212.0k | Unchanged |
| JACOBS LEVY EQUITY MANAGEMENT, INC 0.00% of their portfolio | 161.4k $182.4k | New |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 138.0k $155.9k | Added +69.5k |
| FRED ALGER MANAGEMENT, LLC 0.00% of their portfolio | 123.8k $139.9k | Added +15 |
| TD Asset Management Inc 0.00% of their portfolio | 117.2k $132.4k | Reduced -16.6k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 97.9k $110.0k | Added +5.5k |
| Magnetar Financial LLC 0.00% of their portfolio | 56.9k $64.0k | Added +21.9k |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.00% of their portfolio | 53.1k $65.8k | Added +269 |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 47.6k $54.0k | Reduced -18.2k |
| Ergoteles LLC 0.00% of their portfolio | 30.6k $34.5k | Reduced -38.9k |
| Bank of New York Mellon Corp 0.00% of their portfolio | 29.9k $33.8k | Reduced -1 |
| STATE STREET CORP 0.00% of their portfolio | 26.1k $29.5k | Unchanged |
| Parkwood LLC 0.01% of their portfolio | 24.5k $28.0k | Unchanged |
| NORTHERN TRUST CORP 0.00% of their portfolio | 21.5k $24.3k | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 20.7k $23.4k | New |
| Schonfeld Strategic Advisors LLC 0.00% of their portfolio | 15.0k $16.9k | Added +2.5k |
| MORGAN STANLEY 0.00% of their portfolio | 13.9k $15.7k | Reduced -6.9k |
| BOOTHBAY FUND MANAGEMENT, LLC 0.00% of their portfolio | 12.0k $13.5k | Added +1.9k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 10.4k $12.0k | Reduced -7.0k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 5.7k $6.5k | Added +1.7k |
| Belpointe Asset Management LLC 0.00% of their portfolio | 3.1k $3.5k | New |
| Arena Investors LP 0.00% of their portfolio | 2.0k $2.2k | Reduced -188.1k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 1.3k $1.0k | Reduced -1.4m |
| UBS Group AG 0.00% of their portfolio | 593 $670 | Reduced -1.5k |
| RESOURCES MANAGEMENT CORP /CT/ /ADV 0.00% of their portfolio | 500 $1.0k | Unchanged |
| CITIGROUP INC 0.00% of their portfolio | 138 $156 | Reduced -418 |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 104 $0 | Reduced -712 |
| Advisory Services Network, LLC 0.00% of their portfolio | 100 $113 | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 79 $89 | Added +2 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |